- Home
- IRON vs RNW Comparison
IRON vs RNW Comparison
Compare IRON & RNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRON
- RNW
- Stock Information
- Founded
- IRON 2017
- RNW 2011
- Country
- IRON United States
- RNW United Kingdom
- Employees
- IRON N/A
- RNW N/A
- Industry
- IRON Biotechnology: Pharmaceutical Preparations
- RNW Electric Utilities: Central
- Sector
- IRON Health Care
- RNW Utilities
- Exchange
- IRON Nasdaq
- RNW Nasdaq
- Market Cap
- IRON 1.9B
- RNW 2.2B
- IPO Year
- IRON N/A
- RNW N/A
- Fundamental
- Price
- IRON $52.23
- RNW $6.01
- Analyst Decision
- IRON Strong Buy
- RNW Strong Buy
- Analyst Count
- IRON 10
- RNW 1
- Target Price
- IRON $83.80
- RNW $7.50
- AVG Volume (30 Days)
- IRON 342.1K
- RNW 869.7K
- Earning Date
- IRON 05-08-2025
- RNW 02-18-2025
- Dividend Yield
- IRON N/A
- RNW N/A
- EPS Growth
- IRON N/A
- RNW N/A
- EPS
- IRON N/A
- RNW 0.04
- Revenue
- IRON N/A
- RNW $1,006,524,942.00
- Revenue This Year
- IRON N/A
- RNW N/A
- Revenue Next Year
- IRON N/A
- RNW $38.75
- P/E Ratio
- IRON N/A
- RNW $156.76
- Revenue Growth
- IRON N/A
- RNW N/A
- 52 Week Low
- IRON $25.60
- RNW $5.15
- 52 Week High
- IRON $68.73
- RNW $7.49
- Technical
- Relative Strength Index (RSI)
- IRON 44.88
- RNW 43.92
- Support Level
- IRON $51.57
- RNW $6.04
- Resistance Level
- IRON $53.61
- RNW $6.29
- Average True Range (ATR)
- IRON 2.00
- RNW 0.16
- MACD
- IRON 0.06
- RNW 0.01
- Stochastic Oscillator
- IRON 36.43
- RNW 63.25
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders. The company is building a portfolio of inventive therapeutic candidates that affect fundamental pathways of red blood cell biology. Disc Medicine is committed to developing treatments that empower and bring hope to the many patients who suffer from hematologic disease. The Company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis.
About RNW ReNew Energy Global plc
ReNew Energy Global PLC is a developer and operator of clean energy projects intended to meet India's growing energy needs in an efficient, sustainable and socially responsible manner. The company provides end-to-end solutions in a just and inclusive manner in the areas of clean energy, value-added energy offerings through digitalization, storage, and carbon markets that increasingly are integral to addressing climate change. The company has four reportable segments: wind power and solar power, hydro power and transmission line. It derives maximum revenue from Wind Power segment.